Literature DB >> 15152128

A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention.

Paul T Vaitkus1.   

Abstract

BACKGROUND: While each of the available femoral arterial sealing devices claims equivalent safety to manual compression following invasive cardiac procedures, these claims are based on small, underpowered studies. Our aim was to increase the ability to detect a clinically meaningful difference by performing a meta-analysis.
METHODS: We identified studies via Medline and manual searches and selected studies that were prospective, randomized clinical trials for inclusion. Pooling of data was performed by calculation of the Mantel-Haenszel odds ratio (OR) and the variance of the OR was estimated using the method of Robins, Greenland and Breslow.
RESULTS: Sixteen studies enrolling 5,048 patients were included in the analysis. The pooled OR was 0.89 (95% confidence interval, 0.86-0.91), indicating a significant decrease in risk by devices. Excluding hematomas from the endpoint resulted in a concordant result. Angio-Seal was associated with a significant reduction in risk (OR, 0.51) and Perclose had a neutral result (OR, 1.0), whereas Vasoseal had an increased risk of complications (OR, 1.18).
CONCLUSION: Overall, sealing devices may be associated with a reduction in risk of complications following invasive coronary procedures, but significant differences may exist among individual devices. These potential differences need to be explored in randomized, controlled clinical trials.

Entities:  

Mesh:

Year:  2004        PMID: 15152128

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  22 in total

Review 1.  Radial versus femoral access for percutaneous coronary intervention: implications for vascular complications and bleeding.

Authors:  Sandeep Nathan; Sunil V Rao
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

Review 2.  Achieving safe femoral arterial access.

Authors:  Michael S Lee; Jeremy Kong
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

Review 3.  Percutaneous or surgical access for transfemoral transcatheter aortic valve implantation.

Authors:  Amit N Vora; Sunil V Rao
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

Review 4.  Vascular access and closure in coronary angiography and percutaneous intervention.

Authors:  Robert A Byrne; Salvatore Cassese; Maryam Linhardt; Adnan Kastrati
Journal:  Nat Rev Cardiol       Date:  2012-11-27       Impact factor: 32.419

5.  Bleeding-avoidance strategies and outcomes in patients ≥80 years of age with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the NCDR CathPCI Registry).

Authors:  John A Dodson; Yongfei Wang; Sarwat I Chaudhry; Jeptha P Curtis
Journal:  Am J Cardiol       Date:  2012-04-03       Impact factor: 2.778

6.  Delayed Vascular Claudication Following Diagnostic Cerebral Angiography: A Rare Complication of the AngioSeal Arteriotomy Closure Device.

Authors:  Jacquelyn A Corley; Manish K Kasliwal; Lee A Tan; Demetrius K Lopes
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2014-09-30

7.  Bleeding avoidance strategies. Consensus and controversy.

Authors:  Harold L Dauerman; Sunil V Rao; Frederic S Resnic; Robert J Applegate
Journal:  J Am Coll Cardiol       Date:  2011-06-28       Impact factor: 24.094

8.  Angioseal™ as a hemostatic device for direct carotid puncture during endovascular procedures.

Authors:  Hugo Cuellar; Leopoldo Guimaraens; Sudheer Ambekar; Elio Vivas; Jacques Theron
Journal:  Interv Neuroradiol       Date:  2015-05-11       Impact factor: 1.610

9.  [Arterial closure devices. What device for which clinical situation?].

Authors:  M Treitl; K M Eberhardt; D Maxien; B Behrends; M F Reiser
Journal:  Radiologe       Date:  2013-03       Impact factor: 0.635

10.  Bleeding Complications After PCI and the Role of Transradial Access.

Authors:  Amit N Vora; Sunil V Rao
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.